Matsumoto Ayumi, Matsui Isao, Mori Takayasu, Sakaguchi Yusuke, Mizui Masayuki, Ueda Yoshiyasu, Takahashi Atsushi, Doi Yohei, Shimada Karin, Yamaguchi Satoshi, Kubota Keiichi, Hashimoto Nobuhiro, Oka Tatsufumi, Takabatake Yoshitsugu, Sohara Eisei, Hamano Takayuki, Uchida Shinichi, Isaka Yoshitaka
Department of Nephrology, Osaka University Graduate School of Medicine, Japan.
Department of Nephrology, Graduate School of Medical and Dental Sciences, Tokyo Medical and Dental University, Japan.
Intern Med. 2018 Dec 15;57(24):3603-3610. doi: 10.2169/internalmedicine.1272-18. Epub 2018 Aug 10.
We present a case of Dent disease caused by a novel intronic mutation, 1348-1G>A, of the chloride voltage-gated channel 5 (CLCN5) gene. Cultured proximal tubule cells obtained from the patient showed impaired acidification of the endosome and/or lysosome, indicating that the 1348-1G>A mutation was indeed the cause of Dent disease. Although the prevalence of osteomalacia in Dent disease is low in Japan, several factors-including poor medication adherence-caused severe osteomalacia in the current case. Oral supplementation with calcium and native/active vitamin D therapy, with careful attention to medication adherence, led to the improvement of the patient's bone status.
我们报告了一例由氯离子电压门控通道5(CLCN5)基因的新型内含子突变1348-1G>A引起的丹特病病例。从患者身上获取的培养近端小管细胞显示内体和/或溶酶体酸化受损,表明1348-1G>A突变确实是丹特病的病因。尽管在日本丹特病中骨软化症的患病率较低,但在当前病例中,包括药物依从性差在内的几个因素导致了严重的骨软化症。口服补充钙和天然/活性维生素D治疗,并密切关注药物依从性,使患者的骨骼状况得到改善。